(May 21, 2019, 2:13 PM EDT) -- BOSTON — A federal judge in Massachusetts on May 20 dismissed a Zofran birth defect case with prejudice as to the parents but without prejudice as to the couple’s minor son and ordered the parents to pay defendant GlaxoSmithKline LLC’s (GSK) costs but limited them to $800 (Angela Kutzer, et al. v. GlaxoSmithKline LLC, No. 15-13751, D. Mass. 2019 U.S. Dist. LEXIS 84461)....